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Running title: Sex difference in umbilical cord testosterone 
Summary   
This meta-analysis reviewed published literature comparing 
human male and female umbilical cord total testosterone (T) 
levels. Eighteen studies using 1229 samples from 602 male and 
627 female newborns were analyzed using the RevMan 5 
statistical package. Analysis using the inverse variance method 
based on a random-effects model revealed significantly higher 
cord T in boys than girls at a moderate effect size (Hedges’ g = 
0.57). There was significant heterogeneity between the 18 
studies, though the five studies using direct assays showed no 
heterogeneity. For studies using extraction and 
chromatography, those that combined T from arterial and 
venous cord blood found a larger sex difference than those 
using only cord venous samples (Hedges’ g = 0.94 versus 
0.32); this suggests umbilical cord venous T is of 
maternal/placental origin and arterial T is of fetal origin. The 
wide range of T values between studies suggests high cross-
reactivity in the assay methods reviewed.  
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Introduction 
Barker (2004) proposed that some diseases of adulthood 
may have their origin in conditions in the fetal environment, 
and that low birth weight is associated with insulin resistance, 
type 2 diabetes, hypertension, and coronary heart diseases in 
adults. This hypothesis is supported by research showing that 
elevated maternal testosterone (T) is related to low birth weight 
in sheep (Manikkam et al., 2006) and humans (Carlsen et al., 
2006).  Elevated maternal T in rhesus monkeys in late 
pregnancy causes hyperinsulinemia, and in early pregnancy 
additionally causes type II diabetes (Abbott et al., 2009). 
Elevated maternal T in either early or late gestation doubles the 
risk of the female offspring of rhesus monkeys suffering from 
anovulation and polycystic ovaries in adulthood (Resko et al., 
1987).  Animal research suggests that females may be more 
sensitive to the effects of T on brain development than males 
(Roselli et al., 2007) so it is especially important to assess 
potential risks to the female fetus of exposure to T. However at 
present there is no definitive consensus as to whether T is 
normally lower at birth in the umbilical cord of healthy human 
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females pregnancies than in male, so it has been difficult to 
make clinical judgements regarding prenatal risk of T exposure 
based on levels of umbilical cord T. It is hoped that the 
identification of normative sex differences in T levels in the 
present meta-analysis will contribute to our scientific and 
clinical understanding of this issue. 
Polycystic ovary syndrome (PCOS) affects 5-10% of 
women (Franks, 1995) and is hypothesised to develop as a 
result of exposure to elevated T prenatally (Dumesic et al., 
2006).  Some recent research suggests that umbilical vein T is 
elevated in female newborns of mothers with PCOS (Barry et 
al., 2010).  Placental aromatase is traditionally thought to 
protect the fetus from raised maternal T, but animal research 
contradicts this hypothesis (Resko et al., 1987; Manikkam et 
al., 2006; Abbott et al., 2009). 
To date, studies have produced mixed evidence 
regarding a sex difference in umbilical vein T. Some studies 
have found that compared to female newborns, male newborns 
have more umbilical vein T (Herruzo et al., 1993), less (Pardo 
et al., 1993), or virtually identical levels (van de Beek et al., 
2004). Establishing a norm for umbilical cord T is difficult 
because the commonly used ‘direct’ assay methods (described 
in discussion section, below) lack the sensitivity to accurately 
detect T at levels below 10 nmol/l (Rosner et al., 2007); 
although umbilical vein T tends to be higher than circulating T 
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in women of reproductive age (Baik et al., 2004) it is usually 
below the 10 nmol/l detection threshold suggested for direct 
assays (see Table II).  
 
 Fetal T can be measured from various sites. Although 
amniotic fluid is the best candidate to investigate the effects of 
early fetal androgen exposure (van de Beek et al., 2004), it is 
not comparable to cord T at the end of gestation because 
amniotic T is sampled around weeks 11 to 21 when a sex 
difference in T is likely to largest because of the testosterone 
surge in male fetuses (Smail et al., 1981).  Most studies of fetal 
T sample from the umbilical vein at birth; fewer studies sample 
mixed (arteries + vein) cord blood, and very few sample 
directly from umbilical arteries. Almost all studies measure 
total T rather than free (unbound) T. 
Some papers on this topic (Mathur et al., 1980; Bolton 
et al., 1989; Pardo et al., 1993; Troisi et al., 2003; Anderson et 
al., 2010) speculate or infer that umbilical arterial T is of fetal 
origin and umbilical vein T is of maternal/placental origin. This 
hypothesis has not been proved, but if male fetuses produce 
more T than females, and if the umbilical arteries carry 
hormones of fetal origin, then the umbilical arteries of males 
should contain more T than the arteries of females (i.e. a sex 
difference in arterial T). By extension, because mixed cord T 
contains arterial T, mixed cord T should show a larger sex 
difference than the sex difference for venous T.  
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The objective of the present paper was to discover 
whether there is a sex difference in umbilical vein T across 
comparable studies..  
 
 
 
 
 
Materials and Methods 
Literature search 
All studies that measured testosterone in umbilical cord 
listed in Pubmed and Medline published up to March 1st 2010, 
and EMBASE from 1980 to March 31st 2010, were identified. 
The Cochrane Reviews database was also searched. The 
keyword search terms, ‘umbilical’ ‘cord’ and ‘testosterone’, 
were entered simultaneously. This produced 115 articles from 
Pubmed from 1965 to 2010, and 73 from Medline. Medline 
produced no new papers in addition to those cited in Pubmed. 
EMBASE produced four additional studies, but these did not 
meet the inclusion criteria for the present meta-analysis. The 
“related article” function was used to widen the results. 
Additionally three Mesh searches were performed using firstly 
the terms “testosterone” AND “umbilical cord”, “testosterone” 
AND “umbilical veins”, and “testosterone” AND “umbilical 
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arteries”. This retrieved 52, 26, and 16 publications 
respectively, all of which were previously found using the 
Pubmed keyword search. The Cochrane Reviews database 
produced six publications, but these were not relevant. A hand 
search of relevant articles referenced in these publications were 
obtained, which produced nine publications not previously 
found. Each article was assessed by [authors 1 and 4], and 
articles that fitted the main criteria (assaying T in umbilical 
cord vein in healthy pregnancies) were accessed. 
Methodological quality was assessed based on the criteria of 
the Scottish Intercollegiate Guidelines Network (2010). 
 
Inclusion and exclusion criteria 
Human studies that compared male and female umbilical 
cord total T at birth were eligible for inclusion provided that: 
a. The pregnancies were healthy  
b. The deliveries were spontaneous, or else planned 
caesarean sections 
c. The assay methods were IA, CLIA/ECL, a method 
using extraction, or mass spectrometry. 
Papers with titles or abstracts that indicated that they were not 
relevant (for various reasons e.g. reviews, single case studies 
etc) were excluded. A literature search flow chart (S1), an 
additional Forest plot (S2), table of excluded studies (S3), 
conversion table for T to nmol from other units (S4), and tables 
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of methodological quality (S5a, b, and c) are available as 
supplemental digital content on the JOG website [insert URL].  
Table 1 shows the characteristics of the included studies. 
[Table I.  here] 
  
Of the included studies, six used direct methods (five IA 
and one CLIA/ECL), eleven used extraction methods (9 with 
thin layer chromatography and two with di-ethyl ether 
extraction alone), and one used LCMS. There were no mixed 
cord X-IA studies, and only one direct assay mixed cord study. 
Two studies (Dawood & Saxena, 1977; Bolton et al., 1989) 
measured T in umbilical arteries and vein separately. The 
venous samples for these two studies were included in the 
venous subgroup, and the means of their arterial and venous 
samples combined were included in the mixed cord subgroup. 
Only the venous samples for these two studies were included in 
the ‘all groups’ analysis. Two studies used ‘predominantly’ 
(Abramovich, 1974) or ‘mainly’ (Maccoby et al., 1979) venous 
blood, so were classified as venous. One study did not state 
whether they differentiated between arteries and vein (Gol et 
al., 2004) and was classified as ‘mixed’. Thirteen of the studies 
were classified as being of moderate quality, four were 
classified as poor (Forest et al., 1973; Abramovich, 1974; 
Dawood & Saxena, 1977; Shinkawa et al., 1983) and one 
classified as good (Troisi et al., 2003). 
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Statistical analysis 
Statistical analyses were performed using Review 
Manager, Version 5 (RevMan 5). Heterogeneity tests suggested 
that a random effects model was appropriate to assess the sex 
difference in umbilical vein T levels in seven of the eight 
subgroups and the studies as a whole. The I² value in the direct 
assay subgroup was zero thus suggesting no problem with 
heterogeneity, but in the interests of not risking an 
underestimation of the heterogeneity between studies the more 
conservative random effects model was used rather than fixed 
effects. The inverse variance method was used. The effect size 
was measured as the standard mean difference, calculated using 
Hedges’ g.  By convention, like Cohen’s d the thresholds for 
small, moderate and large Hedges’ g effect sizes are 0.2, 0.5, 
and 0.8 respectively. All T values are presented in nmol/l, and 
were converted from other units for most studies.  
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Results 
Seventy studies of umbilical cord T were retrieved from 
the electronic databases. Eighteen studies using 1229 samples 
(602 male and 627 female) qualified for review according to 
the inclusion criteria. 834 samples were venous (410 male and 
424 female), 395 were mixed (192 male and 203 female), and 
41 were arterial (Bolton et al., 1989), (Dawood & Saxena, 
1977) (21 male and 20 female). Fifty-two trials were excluded. 
Table II shows cord T levels (nmol/l) for the included 
studies.  It can be seen that most studies (16 of 18) found higher 
cord T in boys than girls, and that overall this difference was of 
a moderate effect size (Hedges’ g = .57).  
[Table II. here] 
 
Table III shows the results of meta-analyses. Although 
there was a lot of heterogeneity in the findings (evidenced by 
the large I² values) the various groups based on assay types and 
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sources of serum all indicate significantly higher T in male 
umbilical cord than female.  
[Table III. here] 
Figure 1 shows the Forest plot of sex difference in 
umbilical vein T for all included studies. The findings of the 
studies tend towards the right hand side of the vertical zero 
point, indicating the tendency of the studies to find higher T in 
the umbilical cord of boys.   
[Figure 1 here] 
Figure 2 compares the magnitude of sex differences in 
venous compared to mixed cord blood in studies using 
chromatography with extraction. The findings in the lower 
Forest plot (mixed cord blood) are further to the right of the 
zero point than those in the upper Forest plot (venous cord 
blood); this indicates that T values for boys in the lower plot 
showed a greater sex difference than T values for boys in the 
higher plot. 
[Figure 2 here] 
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Discussion 
Analysis of all eighteen studies combined, and all 
subgroups, revealed significantly higher umbilical cord T in 
boys than girls. There was significant heterogeneity between 
the 18 studies and in all subgroups except for the direct assay 
venous subgroup. The confidence intervals for the subgroups 
were generally narrow and showed effect sizes of clinical 
interest. With the exception of the venous chromatographic 
extraction subgroup the confidence intervals did not encompass 
a zero value, which suggests that overall the sex differences 
were representative of those likely to be seen in the general 
population of newborns. Four of the 18 studies were rated as 
poor, largely due to these papers lacking information regarding 
methodological quality rather than explicitly being of poor 
quality. The four ‘poor’ ratings were on the borderline for 
scores for moderate quality and excluding them from the 
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overall analysis made almost no difference to the results, thus 
their inclusion is appropriate.  
The most widely available assay methods, in 
descending order of accuracy, use mass spectrometry, thin layer 
chromatography (TLC), extraction with ethyl ether, and direct 
measurement (Rosner et al., 2007). A therefore unexpected 
finding of this meta-analysis is that, judging by heterogeneity 
measures, the direct method may be a more reliable indicator 
than extraction methods of the sex difference in cord T. 
However it is likely that the direct method assay detected more 
substances than T alone, and the interference of other steroids 
and substances may have simply masked the heterogeneity 
evidenced in the extraction group. The cross-reacting 
substances are most likely to have been androgens such as 11-
keto-testosterone, 11-beta-OH-testosterone, and 
dihydrotestosterone (Roche Diagnostics, 2000); for this reason 
the direct assay might be viewed as an omnibus measure of 
androgens rather than simply a measure of T. This 
interpretation remains to be confirmed by a superior assay 
method, though it is of interest that Legro et al (2010) recently 
found good correlations between T levels measured using a 
direct assay and using liquid chromatography mass 
spectrometry in women with PCOS. Only one study to date 
(Anderson et al., 2010) has measured T levels in umbilical cord 
samples using liquid chromatography mass spectrometry. 
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Anderson et al found that 14 healthy girls had nonsignificantly 
higher mixed cord T than seven healthy boys (0.66+1.01 vs 
0.49+0.35 nmol/l). Sixty-six percent of these samples (10 of the 
14 female and four of the seven male) had T levels lower than 
the detection limit of 0.24 nmol/l.  These samples were 
assigned a value of 0.24 nmol/l. The fact that the actual T level 
is unknown for 66% of these samples indicates that more 
sensitive mass spectrometry assays are needed.  
Two of the 18 studies (11% of the studies) found that 
girls had higher cord T than boys, and across studies the large 
amount of variation in the observed T levels gives cause for 
concern. Rosner et al. (2007) found that some of their direct 
assays of T in healthy women were roughly 10 times higher 
than others; the present authors found that two studies (Gol et 
al., 2004), (Furuhashi, 1982) reported T values over 100 times 
higher than some other studies using comparable assays and 
sample sites. These studies were of moderate methodological 
quality, and the disparity is not explained by other features of 
the studies. Although the Hedges g values of the two studies are 
in keeping with the other sixteen studies, their relatively high 
observed T values are suggestive of the unreliability of these 
assay types. With the exception of one study (Furuhashi, 1982), 
the extraction methods showed generally lower mean T values 
with a smaller range than the direct assay studies. Because the 
studies included in this meta-analysis are similar in most 
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relevant characteristics, it might be concluded that although the 
direct assays give reliable findings in terms of the size of the 
sex difference, no method appears to yield reliable findings in 
terms of the absolute T levels, especially the direct 
immunoassay due to its poor specificity, cross reactivity with 
other steroids and matrix effects (Rosner et al., 2007).   
A finding of potential clinical importance is that, using 
comparable assays, a larger sex difference was seen in mixed 
cord samples (g = .94, a large effect size) than venous samples 
(g = .32, a small effect size).  This in turn would suggest that 
the higher level in males is due at least part to fetal production.   
This has implications for understanding the etiology of 
conditions such as PCOS in which prenatal T exposure is 
theorised to be a causal factor.  Future studies might compare T 
levels in the umbilical arteries and veins in newborns of women 
with PCOS, and compare these to healthy pregnancies; 
relatively high T in the umbilical arteries compared to the vein 
in PCOS, and higher umbilical arterial T in PCOS compared to 
healthy pregnancies, would suggest fetal T production  in this 
condition. A recent study of PCOS and metformin - a 
medication that lowers T – had the potential to address this 
issue, but interpretation of the findings is difficult because the 
results were not presented for girls whose mothers had PCOS 
and were not taking metformin (Carlsen & Vanky, 2010)  
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The conclusion of this meta-analysis is that although 
there appears to be a reliable sex difference in umbilical vein T 
of a moderate effect size, the direct and extraction assay 
methods lack ecological validity; differences in steroid milieu 
outside that usually used for in vitro diagnostic purposes 
produce wide differences in results where such assays are 
employed to measure specific steroids in real-world samples. 
Current direct assays are known to be poorly discriminative of 
testosterone at low values (Rosner et al., 2007).  This being the 
case, our knowledge of gross T levels in cord blood remains 
limited, and norms for umbilical cord T at birth remain to be 
established through further research using more specific 
methods, such as tandem mass spectrometry. Nevertheless the 
findings of the present meta-analysis suggest that serum in the 
male umbilical cord at birth might contain a higher level of 
androgen than seen in the female cord at birth, and this might 
provide clinicians a rough index (i.e. relative to values seen in 
the opposite sex) as to whether a female newborn has 
experienced elevated androgen prenatally, or whether a male 
newborn has experienced reduced androgen prenatally.  Future 
research might also compare sex hormones in both umbilical 
veins and arteries (not mixed) from male and female progeny as 
way of identifying the source (maternal/placental, or fetal) of 
hormones.  
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Table 1  Study characteristics. 
Study Assay T units Mother Delivery Newborn T source 
Simmer et al (1972)27 C-X-IA “ng %” 
(ng/100ml) 
Not stated Vaginal, term Normal, 
primiparous 
Vein 
Forest et al (1973)25 C-X-IA / l Not stated Normal, vaginal Normal Mixed 
Forest et al (1974)28 C-X-IA ng/100ml Healthy Normal, vaginal Normal Mixed 
Abramovich et al (1974)22 IA ng/100ml Not stated Mix of C-S and vaginal Not stated Mainly venous 
Dawood & Saxena (1977)21 X-IA pg/ml Some amnio. Spontaneous vaginal Not stated Vein  
Maccoby et al (1979)23 C-X-IA ng/ml Not stated Term, no C-S Normal Mostly venous 
Penny et al (1979)29 C-X-IA ng/100 ml Healthy Vaginal Not stated Mixed 
Miyamoto (1981)30 IA ng/ml Not stated normal pregnancy & delivery Term Vein 
Furuhashi et al (1982)31 C-X-IA ng/ml Not stated Normal, vaginal Normal Vein 
Shinkawa et al (1983)26 IA ng/dl Not stated Not stated Term Vein  
Bolton et al (1989)19 C-X-IA nmol/l Not stated Not stated Term Vein  
Herruzo et al (1993)10 IA ng/ml Not stated Uneventful Term Vein  
Simmons et al (1994)32 X-IA nmol/l Healthy Normal Not stated Vein  
Maffeis et al (1999)33 CLIA nmol/l Uncomplicated Uncomplicated Term Vein  
Troisi et al (2003)17 C-X-IA ng/dl Healthy  Normal: SVD or C-S Not stated Mixed  
Van de Beek et al (2004)12 C-X-IA nmol/l Healthy SVD Term Vein 
Gol et al (2004)24 IA ng/ml Healthy Uncomplicated, C-S only Term Mixed (?) 
Anderson et al (2010)15 LCMS ng/dl Healthy 74% SVD; 26% C-S; uncomplicated. >35weeks 
gestation 
Mixed  
 
IA = Direct immunoassay  
CLIA = Direct chemiluminescence immunoassay 
X-IA = IA, after extraction 
C-X-IA = IA, after extraction and chromatography (TLC and/or column) 
LCMS = Liquid Chromatography-Mass Spectrometry. 
C-S = Caesarian section 
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Table 2  Testosterone levels (nmol/l) for all of the included studies, in chronological order. ‘g’ indicates Hedges’ g, the standard mean difference between male and female 
umbilical cord T. Levels for 41arterial samples19, 21 are not shown. 
           Male          Female Difference 
  Mean  SD  n    Mean  SD  n    Hedges’ g [95% CI] 
Simmer et al (1972)27 0.69 0.45 16 0.80 0.52 24 
-0.22 
[-0.85, 0.42] 
Forest et al (1973)25 1.17 0 .33 35 0.92 0.26 46 
0.85 
[0.39, 1.31] 
Forest et al (1974)28 1.24 0.36 51 0.93 0.28 53 
0.96 
[0.55, 1.36] 
Abramovich et al (1974)22 2.92 0.59 20 2.63 1.25 20 
0.29 
[-0.33, 0.91] 
Dawood & Saxena (1977)21 0.79 0.47 11 0.31 0.15 18 
1.51 
[0.65, 2.36] 
Maccoby et al (1979)23 0.97 0.24 58 0.74 0.15 58 
1.14 
[0.75, 1.54] 
Penny et al (1979)29 1.35 0.30 21 0.90 0.25 22 
1.60 
[0.91, 2.30] 
Miyamoto (1981)30 16.69 3.78 55 14.44 3.23 57 
0.64 
[0.26, 1.02] 
Furuhashi et al (1982)31 682.93 43.65 37 659.99 162.2 35 
0.19 
[-0.27, 0.66] 
Shinkawa et al (1983)26 7.67 4.23 45 6.80 2.01 44 
0.26 
[-0.16, 0.68] 
Bolton et al (1989)19 0.34 0.10 12 0.28 0.37 12 
0.21 
[-0.59, 1.02] 
Herruzo et al (1993)10 22.17 11.45 27 14.23 5.62 25 
0.86 
[0.29, 1.43] 
Simmons et al (1994)32 2.10 0.3 62 1.80 0.60 63 
0.63 
[0.27, 0.99] 
Maffeis et al (1999)33 10.40 5.54 48 8.50 4.24 50 
0.38 
[-0.02, 0.78] 
Troisi et al (2003)17 1.01 0.83 49 0.76 0.59 37 
0.34 
[-0.09, 0.77] 
Van de Beek et al (2004)12 4.01 2.50 19 3.72 3.30 18 
0.10 
[-0.55, 0.74] 
Gol et al (2004)24 875.13 121.2 29 809.2 100.2 31 
0.59 
[0.07, 1.11] 
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Anderson et al (2010)15 0.49 0.35 7 0.66 1.01 14 
-0.19 
[-1.10, 0.72] 
Subtotal  
(95% CI) 
 
  602   627 
0.57 
[0.37, 0.77] 
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Table 3  Results of meta-analysis for all studies and the subgroups  
Group Number of 
studies 
Hedges’ g 
[95% CI] 
Z (p) Chi² (p) I² 
All 18 0.57 
[0.37, 0.77] 
5.66 
(P < 0.00001) 
45.96 
(P = 0.0002) 
63% 
All venous 12 0.50 
[0.26, 0.73] 
4.17 
(P < 0.0001) 
28.48 
(P = 0.003) 
61% 
All mixed * 8 0.81 
[0.48, 1.15] 
4.77 
(P < 0.00001) 
17.38 
(P = 0.02) 
60% 
All extraction 11 0.66 
[0.36, 0.95] 
4.31 
(P < 0.0001) 
36.79 
(P < 0.0001) 
73% 
Venous extraction 7 0.51 
[0.09, 0.92] 
2.40 
(P = 0.02) 
24.06 
(P = 0.0005) 
75% 
All C-X-IA 9 0.59 
[0.24, 0.94] 
3.31 
(P = 0.0009) 
33.03 
(P < 0.0001) 
76% 
Venous  
C-X-IA 
5 0.32 
[-0.23, 0.86] 
1.15 
(P = 0.25) 
18.76 
(P = 0.0009) 
79% 
Mixed  
C-X-IA † 
5 0.94 
[0.53, 1.34] 
4.51 
(P < 0.00001) 
11.31 
(P = 0.02) 
65% 
Venous direct ± 5 0.48 
[0.27, 0.68] 
4.62 
(P < 0.00001) 
3.98 
(P = 0.41) 
0% 
95% CI = 95% confidence intervals 
C-X-IA = IA after extraction and chromatography (TLC and/or column) 
*  Includes the mean of umbilical arterial T and umbilical vein T combined, for two studies.19, 21 
† Includes the mean of umbilical arterial T and umbilical vein T combined for one study.19 
± Using the fixed variance method improved results slightly (Z = 4.79, P < 0.00001; g = 0.52 [0.31, 0.73]; Chi² = 
3.78, (P = 0.44); I² = 0%). 
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Table 4. Exclusion criteria and excluded studies (N=115) presented in order of frequency and 
chronologically.   
Studies of T (or aromatase etc) 
function (also usually not 
presented by sex) 
(N=24) 
Cairrão et al (2008)  
Jin et al (2007)  
Perusquía et al (2007)  
Jin et al (2005)  
Zapata et al (2005)  
Yildiz et al (2005)  
Ijiri et al (2003)  
Zhang et al (2002)  
Nie et al (2001)   
Du et al (2001)  
Cid et al (1994) 
Loganath et al (1992) 
Gunasegaram (1991) (EMBASE) 
Higano et al (1989) 
Milewich et al (1987) 
Lewis et al (1986) 
Sybulski et al (1975) 
Ahluwalia et al (1974) (cocaine users) 
Swartz et al (1974) 
Stárka et al (1974) 
Simmer et al (1972) 
Rosenfield (1971)      
Heyns & De Moor (1971) 
Kobayashi et al (1969) 
Animal studies (n=17) Huang et al (2010) 
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Hayashi et al (1997) 
Okamoto et al (1996) 
Heyns et al (1993) 
Mitchell et al (1986) 
Vreeburg et al (1986) 
Ford et al (1980)    
Ellinwood et al (1980) 
Resko (1977)    
Tseng et al (1975) 
Mongkonpunya et al (1975)  
Challis et al (1974) 
Resko (1974) 
Resko (1973)   
Milgrom et al (1973) 
Goy & Phoenix (1972) 
Dang and Meusy-Dessolle (1970) (EMBASE) 
One sex only, or T not 
presented separately for each 
sex (N=17) 
Hickey et al (2010) 
Whitehouse  et al (2010) 
Whitehouse et al (2010) 
Hickey et al (2009) 
Rohrmann et al (2009) 
Troisi et al (2008) 
Nagata et al (2007) (also arteries only) 
Nagata et al (2006) (also arteries only) 
Baik et al (2006)  
Baik et al (2005)   
Schubring et al (1998) 
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Sakai et al (1991) (same sex twins) 
Milewich et al (1990) 
Bradshaw et al (1986) 
Tapanainen et al (1984) (EMBASE)  
Tapanainen (1983) 
Mathur et al (1980)  
Total T not measured or not 
reported (N=12) 
Toth et al (2009) 
Clifton et al (2007) 
Tan & Tan (2001) (unclear if total or free T) 
Fausett et al (1999) 
Maffei et al (1998) 
Gemer et al (1997) (maternal T only) 
Adeyemo & Jeyakumar (1993)  (Free T only) 
Ikegawa (1986) (Free T only) 
Tojo (1981) 
Plotti et al (1975) 
Nunez et al (1974) 
Ermini et al (1974) (T sulphate)  
Same data from another study 
(N=12) 
Faupel-Badger  et al (2009) [Troisi et al’s 2006a  data] 
Savage (2009) (Cohrane cited twice) 
Troisi et al (2006) (b) [Troisi et al’s 2006a data] 
Troisi et al (2006) (c) [Troisi et al’s 2006a data] 
Zupan et al (2004) (Cohrane cited twice) 
Jacklin et al (1988) (same Maccoby et al (1979)) 
Marcus et al (1985) (same Maccoby et al (1979)) 
Jacklin et al (1984) (same Maccoby et al (1979)) 
Jacklin et al (1983) (same Maccoby et al (1979)) 
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Abramovich & Rowe (1973) (almost identical to Abramovich et al 
(1974). (hand search) 
Gandy (1971) (same Gandy (1968)) (hand search) 
Mizuno et al (1968) (Japanese version of (1969) paper) 
double isotope derivative 
assay (N=5) 
Saez & Bertrand (1969) (hand search) 
Mizuno et al (1969) 
Rivarola et al (1968) 
Gandy (1968) (hand search)  
Bertrand & Saez (1968) (hand search) 
Data from unhealthy women 
and/or children &/or 
pregnancy complications or 
healthy women and/or 
children not presented 
separately from other cases 
(N=6) 
Carlsen & Vanky (2010) 
Jin et al (2009)  
Pardo et al (2004) (EMBASE) 
Su et al (1996) 
Simmons (1995) 
Forest et al (1980) 
Single case study (N=4) Bertalan et al (2007) 
da Silva et al (2007) 
Holt et al (2005)  
Hensleigh et al (1975) 
Aborteses  (N=3) Stern et al (1975) 
Reyes et al (1974) (hand search) 
Reyes et al (1973) (hand search) 
Amniotic (N=3) Ahluwalia et al (1992) (also arteries) 
Nagamani et al (1979) (hand search) 
Caputo et al (1974) 
Mean &/or SD not given Adkins et al (2007)   
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(indicating a non-normal 
distribution of values) (N=5) 
Yuguang et al (2007) (geometric mean, no SD; hand search) 
Tan et al (1998) 
Bammann et al (1980) (hand search) 
August et al (1969) 
Sampled mid gestation (N=2) Abramovich  (1974)  
Ling et al (1974) 
Other (N=7) Savage (2009) (ENT, Cochrane review)  
Owens (2008) (vocal cords, Cochrane review) 
Zupan et al (2004) (cord hygiene, Cochrane review) 
Hofmeyr (1997) (cord complications, Cochrane review) 
Ghione et al (1993) (Review; not about cord T) 
Wei et al (1990) (assay methodology) 
Mitchell (1970) (Review) 
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S4.   Conversion of testosterone to nmol/l  from other units 
Units  Conversion factor 
 pg/mL  multiply by 0.00347  
 ng/dL  multiply by 0.0347 
 ng/100ml  multiply by 0.0347  
 ng %  multiply by 0.0347  
ng/100ml multiply by 0.0347 
 mμg/100 ml  multiply by 0.0347 
 μg/dl  multiply by .347  
 ng/mL  multiply by 3.47  
 μg/L  multiply by 3.47 
 pmol/L  multiply by .001 
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S5a. Methodological qualities of prospective studies included (Adapted from the Scottish Intercollegiate 
Guidelines Network).   
1= yes; 0=no.  Maximum score = 20.     Scores of: 0-6 = poor methodology; 7-13 = fair; 14-20 =good. 
Quality variables  Simmer 
et al 
(1972) 
Forest 
et al 
(1973) 
Forest 
et al 
(1974) 
Abram
ovich 
et al 
(1974) 
Dawoo
d & 
Saxena 
(1977) 
Macc
oby 
et al 
(1979) 
Inclusion Criteria  0 0 0 0 1 1 
Exclusion Criteria  0 0 1 0 0 1 
Demographics comparable 0 0 0 0 0 0 
Can the number of participating centers be 
determined  
0 0 1 0 0 1 
Has the source of cord T been identified (e.g. 
vein) 
1 1 1 1 1 1 
Are the mother’s baseline characteristics 
comparable in the two groups 
0 0 1 0 0 0 
Are the children’s baseline characteristics 
comparable in the two groups 
1 1 1 0 0 1 
Can the number of hospital staff taking cord 
samples be determined  
0 0 0 0 0 0 
Can the reader determine how expert the 
sampler was 
0 0 0 0 0 0 
Can the reader determine how expert the lab 
technician (assayer) was  
1 0 0 1 0 0 
Is the cord sampling technique adequately 
described  
1 0 1 1 1 1 
Is the assay technique adequately described 1 1 1 1 1 1 
Is there any way that they have tried to 
standardize the cord sampling technique  
1 0 1 0 1 1 
Is there any way that they have tried to 
standardize the assay technique 
1 1 1 1 1 1 
Is the delivery type identified 1 1 1 0 0 1 
Is the delivery type comparable in the two 
groups 
1 1 1 0 0 1 
Do authors address whether there is any 
missing data  
0 0 0 0 0 0 
Was the study period stated  0 0 0 0 0 1 
Is it clear whether all the patients asked to 
enter the study took part  
0 0 0 0 0 1 
Analysis by intention to treat  0 0 0 0 0 0 
Score  9 6 11 5 6 13 
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S5b. Methodological qualities of prospective studies included (Adapted from the Scottish Intercollegiate 
Guidelines Network).   
1= yes; 0=no.  Maximum score = 20.     Scores of: 0-6 = poor methodology; 7-13 = fair; 14-20 =good. 
Quality variables  Penny et 
al (1979) 
Miyam
oto 
(1981) 
Furuh
ashi et 
al 
(1982) 
Shinka
wa et al 
(1983) 
Bolton 
et al 
(1989) 
Herru
zo et 
al 
(1993) 
Inclusion Criteria  0 0 0 0 0 1 
Exclusion Criteria  1 1 0 0 0 0 
Demographics comparable 0 1 0 0 0 0 
Can the number of participating centers be 
determined  
0 0 0 0 0 1 
Has the source of cord T been identified (e.g. 
vein) 
1 1 1 1 1 1 
Are the mother’s baseline characteristics 
comparable in the two groups 
1 0 0 0 0 0 
Are the children’s baseline characteristics 
comparable in the two groups 
0 1 1 1 1 1 
Can the number of hospital staff taking cord 
samples be determined  
0 0 0 0 0 0 
Can the reader determine how expert the 
sampler was 
0 0 0 0 0 0 
Can the reader determine how expert the lab 
technician (assayer) was  
0 1 0 1 0 1 
Is the cord sampling technique adequately 
described  
1 0 1 0 1 1 
Is the assay technique adequately described 1 1 1 1 1 1 
Is there any way that they have tried to 
standardize the cord sampling technique  
0 0 1 0 1 0 
Is there any way that they have tried to 
standardize the assay technique 
1 1 1 1 1 1 
Is the delivery type identified 1 1 1 1 1 1 
Is the delivery type comparable in the two 
groups 
1 1 1 0 0 1 
Do authors address whether there is any 
missing data  
0 0 0 0 0 0 
Was the study period stated  0 0 0 0 0 1 
Is it clear whether all the patients asked to 
enter the study took part  
0 0 0 0 0 0 
Analysis by intention to treat  0 0 0 0 0 0 
Score  8 9 8 6 7 11 
 
 
 
 
39 
 
S5c. Methodological qualities of prospective studies included (Adapted from the Scottish Intercollegiate 
Guidelines Network).   
1= yes; 0=no.  Maximum score = 20.     Scores of: 0-6 = poor methodology; 7-13 = fair; 14-20 =good. 
Quality variables  Simmons 
et al 
(1994) 
Maffeis 
et al 
(1999) 
Troisi 
et al 
(2003) 
Van de 
Beek et 
al 
(2004) 
Gol et 
al 
(2004) 
Ande
rson 
et al 
(2010) 
Inclusion Criteria  1 0 1 1 1 1 
Exclusion Criteria  1 0 1 1 0 1 
Demographics comparable 1 0 0 0 1 1 
Can the number of participating centers be 
determined  
0 0 1 1 0 0 
Has the source of cord T been identified (e.g. 
vein) 
1 1 1 1 0 1 
Are the mother’s baseline characteristics 
comparable in the two groups 
1 1 1 1 1 1 
Are the children’s baseline characteristics 
comparable in the two groups 
0 1 0 1 1 0 
Can the number of hospital staff taking cord 
samples be determined  
0 0 0 0 0 0 
Can the reader determine how expert the 
sampler was 
0 0 0 0 0 0 
Can the reader determine how expert the lab 
technician (assayer) was  
0 1 0 0 1 0 
Is the cord sampling technique adequately 
described  
1 1 1 0 0 1 
Is the assay technique adequately described 1 1 1 1 1 1 
Is there any way that they have tried to 
standardize the cord sampling technique  
1 1 1 0 0 1 
Is there any way that they have tried to 
standardize the assay technique 
1 1 1 1 1 1 
Is the delivery type identified 1 1 1 1 1 1 
Is the delivery type comparable in the two 
groups 
1 1 1 1 1 1 
Do authors address whether there is any 
missing data  
1 0 1 1 0 1 
Was the study period stated  0 0 1 1 0 0 
Is it clear whether all the patients asked to 
enter the study took part  
0 0 1 0 0 0 
Analysis by intention to treat  0 0 0 0 0 0 
Score  12 10 14 12 9 12 
 
 
 
 
 
